ABSTRACT
Introduction Lung cancer is the most common cancer in the world, and the majority of lung cancer patients are above the age of 65 years. The changing demographics will result in an even higher number of senior people who will develop lung cancer and are in need of subsequent cancer treatment and care. This patient population may suffer from other comorbid conditions or geriatric syndromes, complicating their treatment and care.
